ITGAM and breast cancer: A recent study performed by USA researchers has shown that innate granulocytes with phenotypes of CD15hiCD33low in blood, and CD11b+CD15+HLA-DR− in tumor tissues, are increased and activated in BC patients, and that these cells exert immunosuppressive activity on T cell proliferation in vitro [17].